New Clinical Data and Insurance Coverage Support Mederi's Stretta Therapy for GERD
RCT shows Stretta wins over PPI, and new coverage policy issued by Capital Blue Cross in PA
NORWALK, Conn., Nov. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Mederi is pleased to announce publication of a new randomized, controlled trial as wel... Devices, Gastroenterology, Reimbursement Mederi Therapeutics, Stretta Therapy, Gastroesophageal Reflux Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Insurance | Marketing